Status:
COMPLETED
A Study of T3 Therapy in Patients With Hypothyroidism
Lead Sponsor:
Ipe, LLC
Conditions:
Hypothyroidism
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to test a new thyroid hormone preparation. The thyroid gland produces two thyroid hormones: mostly T4 and a smaller amount of T3. Thyroid hormone therapy for hypothyroidis...
Eligibility Criteria
Inclusion
- Hypothyroid patients taking levothyroxine
- Age 18-65
- Able to make weekly in-person visits to Washington, D.C.
Exclusion
- Pregnancy or lactation
- Chronic medical conditions such as heart disease or any other chronic medical conditions such as lung disease (e.g. asthma), kidney disease (e.g. kidney failure), liver disease (e.g. hepatitis), diabetes, or cancer.
- Steroid medications such as estrogen, progesterone, estrogen or progesterone related medications, testosterone, or glucocorticoids
- Already taking T3
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01800617
Start Date
March 1 2013
Last Update
July 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University Hospital
Washington D.C., District of Columbia, United States, 20007